Clinical Trial Update: Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated microwave ablation combined with camrelizumab for early breast cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED